missing translation for 'onlineSavingsMsg'
Learn More
Learn More
GSK 2193874
Potent and selective TRPV4 antagonist; orally active
1820.69 SEK - 5918.85 SEK
Specifications
| Chemical Name or Material | 3-([1,4'-Bipiperidin]-1'-ylmethyl)-7-bromo-N-(1-phenylcyclopropyl)-2-[3-(trifluoromethyl)phenyl]-4-quinolinecarboxamide |
|---|---|
| CAS | 1336960-13-4 |
| Assay Percent Range | >98% |
| Molecular Formula | C37H38BrF3N4O |
| Formula Weight | Observed MW: 691.62 |
| Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
|---|---|---|---|---|---|---|---|---|---|
| Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
|
18750809
|
Tocris
5106/5 |
5 mg |
1820.69 SEK
5mg |
Estimated Shipment: 09-09-2024 Log in to see stock. |
Please sign in to purchase this item. Need a web account? Register with us today! | ||||
|
18757646
|
Tocris
5106/25 |
25 mg |
5918.85 SEK
25mg |
Estimated Shipment: 09-09-2024 Log in to see stock. |
Please sign in to purchase this item. Need a web account? Register with us today! | ||||
Description
Potent and selective TRPV4 antagonist (IC50 values are 2 and 40 nM for rat and human receptors, respectively); inhibits Ca2+ influx through TRPV4 channels. Prevents and reverses pulmonary edema after myocardial infarction in vivo models. Selective over a panel of ∽200 human receptors, channels and enzymes. Orally active.Specifications
| 3-([1,4'-Bipiperidin]-1'-ylmethyl)-7-bromo-N-(1-phenylcyclopropyl)-2-[3-(trifluoromethyl)phenyl]-4-quinolinecarboxamide | |
| >98% | |
| Observed MW: 691.62 |
| 1336960-13-4 | |
| C37H38BrF3N4O |